View live charts, options flow & technicals for DaVita Inc. →
Open Dashboard
DaVita Inc. (DVA) is a healthcare company in the medical care facilities industry with $14.01B in trailing revenue trading at a 15.1× trailing P/E — analyst consensus: buy.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Key Statistics
Market Cap
$11.39B
Revenue (TTM)
$14.01B
EPS (TTM)
$11.80
EPS (Fwd est.)
$17.14
Employees
78,000
Trailing P/E
15.12
Forward P/E
10.41
PEG Ratio
0.43
Price / Sales
0.81
Price / Book
-14.92
EV / EBITDA
9.18
Beta (5Y)
0.83
Analyst Consensus
Consensus
Buy
Analyst Price Target
+23.2% upside
Target: $219.86
Annual Revenue & Net Income
RevenueNet Income
'22
$11.61B
$560.00M
'23
$12.14B
$690.00M
'24
$12.82B
$940.00M
'25
$13.64B
$750.00M
Earnings History
Quarter
Actual EPS
Estimate
Result
Aug 2026
$4.02
$3.88
Beat (+3.5%)
May 2026
$2.87
$2.33
Beat (+23.2%)
Feb 2026
$3.40
$3.19
Beat (+6.5%)
Oct 2025
$2.51
$3.17
Miss (-20.9%)
Next Earnings Report
DaVita Inc. is next expected to report earnings on 28 Oct 2026.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dia…
What is DVA's market cap?
DaVita Inc. has a market capitalization of approximately $11.39B.
What is DVA's P/E ratio?
DaVita Inc. trades at a trailing P/E ratio of 15.1x and a forward P/E of 10.4x, which is below the broad market average of ~25x.
How much revenue does DVA generate?
DaVita Inc. generated $14.01B in trailing 12-month revenue.
What do analysts say about DVA?
The analyst consensus rating for DaVita Inc. is buy, with a mean price target of $219.86. That implies +23.2% upside from the current price.
When does DVA report earnings?
DaVita Inc. is next scheduled to report earnings on 28 Oct 2026.
Does DVA pay a dividend?
DaVita Inc. does not currently pay a regular dividend.
View live charts, options flow, gamma exposure, earnings history, and technical analysis for DaVita Inc. on Apsis Markets.
